Personalis, Inc. Common Stock PSNL
HEALTHCARE · DIAGNOSTICS & RESEARCHi
Market dataready · fetched 2026-11-12T02:57:04.304Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-11T21:00:01.425828289Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-12T02:57:03.856983+00:00
Personalis, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 14.91 | 54.4% | 7.5% | |||
| 25Δ | 28.59 | 382.6% | 85.9% | 15.23 | 55.4% | 6.5% |
| 30Δ | 19.70 | 178.8% | 27.7% | 15.48 | 59.6% | 6.1% |
| 35Δ | 19.28 | 166.3% | 25.2% | 15.73 | 63.8% | 5.6% |
| 40Δ | 18.86 | 153.7% | 22.8% | 15.98 | 68.0% | 5.2% |
| 45Δ | 18.43 | 141.1% | 20.3% | 16.23 | 72.2% | 4.7% |
| 50Δ | 18.01 | 128.5% | 17.9% | 16.47 | 76.4% | 4.3% |
| 55Δ | 17.58 | 115.9% | 15.5% | 16.72 | 80.6% | 3.8% |
| 60Δ | 17.16 | 103.3% | 13.0% | 16.97 | 84.8% | 3.4% |
| 65Δ | 16.73 | 90.7% | 10.6% | 17.22 | 89.0% | 2.9% |
| 70Δ | 16.31 | 78.1% | 8.1% | 17.46 | 93.2% | 2.5% |
| 75Δ | 15.89 | 65.5% | 5.7% | |||
| 80Δ | 15.46 | 52.9% | 3.2% | 22.04 | 205.6% | 2.9% |
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 14.91
- IV
- 54.4%
- B/E move
- 7.5%
25Δ
- Pseudo strike
- 28.59
- IV
- 382.6%
- B/E move
- 85.9%
- Pseudo strike
- 15.23
- IV
- 55.4%
- B/E move
- 6.5%
30Δ
- Pseudo strike
- 19.70
- IV
- 178.8%
- B/E move
- 27.7%
- Pseudo strike
- 15.48
- IV
- 59.6%
- B/E move
- 6.1%
35Δ
- Pseudo strike
- 19.28
- IV
- 166.3%
- B/E move
- 25.2%
- Pseudo strike
- 15.73
- IV
- 63.8%
- B/E move
- 5.6%
40Δ
- Pseudo strike
- 18.86
- IV
- 153.7%
- B/E move
- 22.8%
- Pseudo strike
- 15.98
- IV
- 68.0%
- B/E move
- 5.2%
45Δ
- Pseudo strike
- 18.43
- IV
- 141.1%
- B/E move
- 20.3%
- Pseudo strike
- 16.23
- IV
- 72.2%
- B/E move
- 4.7%
50Δ
- Pseudo strike
- 18.01
- IV
- 128.5%
- B/E move
- 17.9%
- Pseudo strike
- 16.47
- IV
- 76.4%
- B/E move
- 4.3%
55Δ
- Pseudo strike
- 17.58
- IV
- 115.9%
- B/E move
- 15.5%
- Pseudo strike
- 16.72
- IV
- 80.6%
- B/E move
- 3.8%
60Δ
- Pseudo strike
- 17.16
- IV
- 103.3%
- B/E move
- 13.0%
- Pseudo strike
- 16.97
- IV
- 84.8%
- B/E move
- 3.4%
65Δ
- Pseudo strike
- 16.73
- IV
- 90.7%
- B/E move
- 10.6%
- Pseudo strike
- 17.22
- IV
- 89.0%
- B/E move
- 2.9%
70Δ
- Pseudo strike
- 16.31
- IV
- 78.1%
- B/E move
- 8.1%
- Pseudo strike
- 17.46
- IV
- 93.2%
- B/E move
- 2.5%
75Δ
- Pseudo strike
- 15.89
- IV
- 65.5%
- B/E move
- 5.7%
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- 15.46
- IV
- 52.9%
- B/E move
- 3.2%
- Pseudo strike
- 22.04
- IV
- 205.6%
- B/E move
- 2.9%
Options history
Table
| Date | IV (%) |
|---|---|
| 77.05% | |
| 95.83% | |
| 93.87% | |
| 95.81% | |
| 63.78% | |
| 61.04% | |
| 59.11% | |
| 63.57% | |
| 73.95% |
Diagnostics & Research
QGEN
QIAGEN NV provides sample-to-knowledge solutions that transform biological materials into molecular knowledge globally. The company is headquartered in Venlo, the Netherlands.
More →RDNT
RadNet, Inc., provides outpatient imaging services in the United States. The company is headquartered in Los Angeles, California.
More →RVTY
Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets globally. The company is headquartered in Waltham,…
More →SHC
Sotera Health Company provides sterilization, laboratory testing, and advisory services to the medical device, pharmaceutical, and food industries in the Americas, Europe, and…
More →TMO
Description unavailable
More →VCYT
Description unavailable
More →